Spring Creek Capital’s ResMed RMD Stock Holding History

Spring Creek Capital’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-12,057	Closed	-$1.25M	–	545
2018 Q2	$1.25M	Buy	+12,057	New	+$1.22M	0.14%	74

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Spring Creek Capital's RMD Position: Q3 2018 in Review

Spring Creek Capital sold out of ResMed (RMD) in Q3 2018, closing a stake of 12,057 shares — an estimated $1.25M sold.

Spring Creek Capital first reported a position in RMD in Q2 2018 and held it in 1 quarter. The position peaked at $1.25M in Q2 2018. 497 funds tracked by Wall St. Rank hold RMD as of Q3 2018.

Spring Creek Capital reported no remaining ResMed position as of Q3 2018 after selling out during the quarter.
Spring Creek Capital sold 12,057 ResMed shares in Q3 2018, an estimated $1.25M.
Spring Creek Capital first reported a position in ResMed in Q2 2018 and held it in 1 quarter.
Spring Creek Capital's ResMed position peaked at $1.25M in Q2 2018.
497 funds tracked by Wall St. Rank held ResMed as of Q3 2018.

Based on Spring Creek Capital's 13F filing for Q3 2018, filed 13 Nov 2018.